NANO MRNA Co.,Ltd. (TYO:4571)
133.00
-1.00 (-0.75%)
May 2, 2025, 3:30 PM JST
NANO MRNA Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2010 | FY 2009 | FY 2008 | 2006 - 2007 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '10 Mar 31, 2010 | Mar '09 Mar 31, 2009 | Mar '08 Mar 31, 2008 | 2006 - 2007 |
Cash & Equivalents | 2,317 | 2,077 | 2,811 | 651.53 | 914.87 | 1,302 | Upgrade
|
Short-Term Investments | 1,200 | 2,200 | 1,632 | 354.78 | 454.14 | 452.3 | Upgrade
|
Cash & Short-Term Investments | 3,517 | 4,277 | 4,443 | 1,006 | 1,369 | 1,755 | Upgrade
|
Cash Growth | -20.56% | -3.74% | 341.51% | -26.49% | -21.98% | 2.11% | Upgrade
|
Accounts Receivable | 33 | 28 | 35 | 5.91 | 43.28 | 0.31 | Upgrade
|
Other Receivables | - | - | - | 11.32 | 15.09 | 15.72 | Upgrade
|
Receivables | 33 | 28 | 35 | 17.23 | 58.36 | 16.04 | Upgrade
|
Inventory | - | - | - | 22.07 | 11.43 | 121.17 | Upgrade
|
Prepaid Expenses | - | - | - | 20.05 | 10.94 | 63.15 | Upgrade
|
Other Current Assets | 154 | 157 | 190 | 0.05 | 0.02 | 0.02 | Upgrade
|
Total Current Assets | 3,704 | 4,462 | 4,668 | 1,066 | 1,450 | 1,955 | Upgrade
|
Property, Plant & Equipment | - | - | - | 23.9 | 29.22 | 32.29 | Upgrade
|
Long-Term Investments | 478 | 609 | 1,115 | - | - | - | Upgrade
|
Other Intangible Assets | - | - | - | 34.71 | 38.22 | 45.01 | Upgrade
|
Other Long-Term Assets | - | - | 1 | 11.03 | 12.13 | 11.91 | Upgrade
|
Total Assets | 4,182 | 5,071 | 5,784 | 1,135 | 1,529 | 2,044 | Upgrade
|
Accounts Payable | 1 | - | 6 | 38.59 | 38.23 | 88.81 | Upgrade
|
Accrued Expenses | - | - | - | 18.17 | 19.34 | 22.55 | Upgrade
|
Current Income Taxes Payable | 9 | 17 | 5 | 7.97 | 7.95 | 8.43 | Upgrade
|
Other Current Liabilities | 598 | 469 | 353 | 56.16 | 5.56 | 16.65 | Upgrade
|
Total Current Liabilities | 1,148 | 486 | 364 | 120.88 | 71.09 | 136.44 | Upgrade
|
Long-Term Debt | - | 1,108 | 1,108 | - | - | - | Upgrade
|
Long-Term Deferred Tax Liabilities | - | - | 9 | - | - | - | Upgrade
|
Other Long-Term Liabilities | 54 | 57 | 50 | 0 | - | - | Upgrade
|
Total Liabilities | 1,202 | 1,651 | 1,531 | 120.88 | 71.09 | 136.44 | Upgrade
|
Common Stock | 166 | 142 | 119 | 2,692 | 2,668 | 2,630 | Upgrade
|
Additional Paid-In Capital | 5,546 | 5,522 | 5,499 | 2,673 | 2,649 | 2,611 | Upgrade
|
Retained Earnings | -2,746 | -2,151 | -1,371 | -4,353 | -3,858 | -3,334 | Upgrade
|
Comprehensive Income & Other | 14 | -93 | 6 | 2.76 | - | 0.05 | Upgrade
|
Shareholders' Equity | 2,980 | 3,420 | 4,253 | 1,014 | 1,458 | 1,908 | Upgrade
|
Total Liabilities & Equity | 4,182 | 5,071 | 5,784 | 1,135 | 1,529 | 2,044 | Upgrade
|
Total Debt | 540 | 1,108 | 1,108 | - | - | - | Upgrade
|
Net Cash (Debt) | 2,977 | 3,169 | 3,335 | 1,006 | 1,369 | 1,755 | Upgrade
|
Net Cash Growth | -10.30% | -4.98% | 231.41% | -26.49% | -21.98% | 2.11% | Upgrade
|
Net Cash Per Share | 42.25 | 45.08 | 47.58 | 78.80 | 109.49 | 194.09 | Upgrade
|
Filing Date Shares Outstanding | 70.6 | 70.38 | 70.14 | 13.34 | 12.71 | 12.3 | Upgrade
|
Total Common Shares Outstanding | 70.6 | 70.38 | 70.14 | 12.86 | 12.71 | 12.3 | Upgrade
|
Working Capital | 2,556 | 3,976 | 4,304 | 944.83 | 1,379 | 1,819 | Upgrade
|
Book Value Per Share | 42.21 | 48.59 | 60.64 | 78.90 | 114.75 | 155.15 | Upgrade
|
Tangible Book Value | 2,980 | 3,420 | 4,253 | 979.76 | 1,420 | 1,863 | Upgrade
|
Tangible Book Value Per Share | 42.21 | 48.59 | 60.64 | 76.20 | 111.74 | 151.49 | Upgrade
|
Buildings | - | - | - | 31.77 | 31.77 | 31.77 | Upgrade
|
Machinery | - | - | - | 248.54 | 248.05 | 267.77 | Upgrade
|
Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.